Thursday
Registration
Pre-SASRO Proton Therapy Symposium
09:00 - 09:10 Welcome & Opening
Chairs:
Damien C. Weber, Paul Scherrer Institut, Villigen
Jean Bourhis, Centre Hospitalier Universitaire Vaudois, Lausanne
09:10 - 10:30 Clinical
Chair:
Damien C. Weber, Paul Scherrer Institut, Villigen
09:10 Proton Therapy in Switzerland and Europe
Damien C. Weber, Paul Scherrer Institut, Villigen
09:30 Indications for protons
Marc Walser, Paul Scherrer Institut, Villigen
10:00 Clinical case studies
Alessandra Bolsi & Sébastien Tran, Paul Scherrer Institut, Villigen
10:30 - 11:20 Physics & Medical Physics
Chair:
Tony Lomax, Paul Scherrer Institut, Villigen
10:30 Rapid referrals: from Papyrus to the XXI century
Tony Lomax, Paul Scherrer Institut, Villigen
10:50 Advanced delivery
David Meer, Paul Scherrer Institut, Villigen
11:05 Medical physics research and development
Francesca Albertini, Paul Scherrer Institut, Villigen
11:20 - 11:30 Summary & Closing Remarks
Chairs:
Damien C. Weber, Paul Scherrer Institut, Villigen
Jean Bourhis, Centre Hospitalier Universitaire Vaudois, Lausanne
SHN Board meeting
Chair:
Stephan Bodis, Cantonal Hospital Aarau
SHN meeting
Chair:
Stephan Bodis, Cantonal Hospital Aarau
Head of Departement meeting
Chair:
Oscar Matzinger, Swiss Medical Network, Genolier
Lunch symposium including lunch: “Improving survival by combining immunotherapy and radiotherapy” AstraZeneca
Chair:
Jean Bourhis, Centre Hospitalier Universitaire Vaudois, Lausanne
How immuno-oncology is “re-shaping” lung cancer treatment
Solange Peters, Head Medical Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne
PACIFIC study and AstraZeneca study program on immunotherapy and radiotherapy
Simon Dovedi, Senior Scientist, AstraZeneca, Cambridge (UK)
Welcome opening
SASRO Presidents
Daniel Zwahlen, Cantonal Hospital Winterthur & Günther Gruber, Clinic Hirslanden, Zurich
Chair of the SASRO 2019 Conference
Jean Bourhis, Centre Hospitalier Universitaire Vaudois, Lausanne
Keynote lecture (I): Combining new systemic agents with radiotherapy: why & how to do it ?
Keynote speaker
Kevin Harrington, The Institute of Cancer Research, London (UK)
Multidisciplinary Symposium Stereotactic Body Radiotherapy (SBRT)
Chairs:
Nicolaus Andratschke, University Hospital, Zurich & Alessandra Pellanda Franzetti, Luganese Clinic Moncucco, Lugano
Should 5 fractions SBRT replace 39 fractions conventional RT for localized prostate carcinoma ? (20')
Thomas Zilli, HUG, Geneva
SBRT for ventricular tachycardia (25')
The cardiologist, Etienne Pruvot and the radiation oncologist perspectives, Raphael Jumeau, Centre Hospitalier Universitaire Vaudois, Lausanne
Liver metastases: is SBRT superior to radiofrequency ablation? (20')
Eric Lartigau, Centre Oscar Lambret, Lille (FR)
Poster discussion: Multidisciplinary session (Physics / Clinical / Biology) Questions / Answers with investigators (10 abstracts)
Presenters and chairs:
Frank Zimmermann,University Hospital, Basel & Maud Jaccard, HUG, Geneva
Coffee Break / Visit to the booths and poster viewing
RTT: Heads of technicians
Up-date 2018-2019 : What were the most important advances?
Chairs:
Jean-Yves Ray, Hopital du Valais, Sion & Abdelkarim Allal HFR, Fribourg
For medical physics?
Peter Manser, Inselspital Bern
For radiation oncology?
Matthias Guckenberger, University Hospital, Zurich
Highlight of the proffered papers (I): Multidisciplinary oral session physics / clinical / biology)
Chairs:
Regina Seiler, Cantonal Hospital Luzern & Damien C. Weber, Paul Scherrer Institut, Villigen (8’ minutes + 2’ discussion per presentation)
- Does hyperthermia clinically alter the α/β? Insights from thermoradiotherapy vs. radiotherapy trials (Niloy Ranjan Datta, Kantonsspital Aarau)
- Fully automated organs at risk delineation for brain tumor radiation planning in patients with glioblastoma using deep learning (Evelyn Herrmann, Inselspital Bern)
- Phase I results of the ONE SHOT Trial (Achard Vérane, HUG)
- Gain of function and analgesia from low dose radiotherapy in musculoskeletal disorders (Susanne Rogers, Kantonsspital Aarau)
- End to end dosimetric and geometric accuracy of a magnetic resonance guided linear accelerator (Luisa Sabrina Stark, University Hospital Zurich)
SRO General Assembly
Friday
Registration
Educational sessions in parallel:
Chair:
Urs Meier, Cantonal Hospital, Winterthur
Hyperthermia: Overview of the clinically validated indications
Stephan Bodis, Cantonal Hospital Aarau
Niloy Ranjan Datta, Cantonal Hospital Aarau
Educational sessions in parallel:
Chairs:
Marc Pachoud, Hospital Riviera-Chablais, Vevey & Pierre Tercier, University of Fribourg
Multi-criteria optimization
Hunor Benedek, Skane University Hospital, Lund (SWE)
Multidisciplinary session : Immunotherapy and radiotherapy
Chairs:
Pelagia Tsoutsou, CHUV, Neuchatel & Oliver Riesterer, Cantonal Hospital, Aarau
What the radiation oncologist, physicist, RTT and nurse should know about immunotherapy and radiotherapy?
Fernanda Herrera, Centre Hospitalier Universitaire Vaudois, Lausanne
Debate: Hypofractionation in Breast Cancer?
Chairs & introduction:
Jacques Bernier, Genolier Clinic & Kaouthar Khanfir, Valais Hospital, Sion
Motion: This house believes that hypofractionation is the standard of care after tumorectomy
9:30 In favor: Birgitte Vrou Offersen, Aarhus University Hospital (DNK)
9:50 Against: Daniel Zwahlen, Cantonal Hospital Winterthur
Welcome RTTs
Jean Bourhis, Centre Hospitalier Universitaire Vaudois, Lausanne
Nurse: General Assembly
Presenter:
Susanne Sester, President, Inselspital Bern
RTT Session 1: Proffered papers
Chair:
Christopher Winter, Cantonal Hospital Graubünden, Graubünden
- Initial clinical experience with the MR-Linac System - Treatment workflow management (USZ)
- Use of Pseudo CT for dose calculation of treatment plans on the Viewray MRIdian Linac (USZ)
- Chabner XRT CIVCO Bra: Clinical Application at KSGR (Kantonsspital Graubünden)
Highlights of the proffered papers (II): Multidisciplinary oral session (medical physics & clinical)
Chair:
Ludwig Plasswilm, Cantonal Hospital St. Gallen & Jan Unkelbach, University Hospital, Zurich
(8’ for each oral presentation + 2’ for questions x 6 presentations)
- Extremely hypofractionated salvage radiotherapy for isolated local recurrent prostate cancer: toxicity and biochemical control (Nicolas Bachmann, Inselspital Bern)
- Quality Assurance for the adaptive workflow on the MRI Linac (Lotte Wilke, University Hospital Zurich)
- Evaluation of an automatic planning solution for breast cancer (Jessica van Rossum, University Hospital Zurich)
- Salvage Radiotherapy for Pelvic Nodal Recurrences of Prostate Cancer after Radical Prostatectomy: A National Survey on Patterns of Practice (Paul Martin Putora, Kantonsspital St. Gallen)
- Impact of vestibule dose on dizziness after radiosurgery for the treatment of vestibular schwannoma (Ekin Ermis, Inselspital Bern)
- MR-guided adaptive SBRT for prostate cancer: stability of adaptive planning analyzed by repetitive imaging (Jana Heitmann, University Hospital Zurich)
Coffee Break for Nurses
Coffee Break for Biologists, Oncologists and Physicists
Joint session Nurses & RTT breathing control
Chair:
Florence Kaufmann Center Hospitalier Universitaire Vaudois, Lausanne
Introduction (10')
Nicolas Péguret, Clinique des Grangettes, Geneva
Percussion Assisted Radiotherapy (PART) versus Active breath hold
Presenters: Frédéric Duclos & Florece Kaufmann, Centre Hospitalier Universitaire Vaudois, Lausanne
Keynote lectures (II)
Chair:
Jean Bourhis, Centre Hospitalier Universitaire Vaudois, Lausanne
How Artificial intelligence will change the radiation oncology landscape in 10 years from now?
Keynote speaker: Ben Heijmen, Erasmus MC Caner Institute, Rotterdam (NLD)
What Future for immuno-oncology?
Keynote speaker: George Coukos, Center Hospitalier Universitaire Vaudois, Lausanne
Lunch Break and poster viewing
3 Lunch Symposia inlcuding Lunch
A shared Vision for the Future of Adaptive Care
Ekta Jhala, Varian Medical Systems International AG, Steinhausen
12:30 - 13:00 Varian, Plenary room
MRgRT in reality: clinical experience of Elekta Unity
Susan Lalondrelle, Royal Marsden Hospital / ICR, London (UK)
13:00 - 13:30 Elekta, room 4BC
Towards adaptive radiotherapy QA with TomoTherapy®
Raphaël Moeckli, Centre Hospitalier Universitaire Vaudois, Lausanne
13:00 - 13:30 Accuray, room 5BC
Nurse: Prostate cancer: expérience de la radiothérapie hypofractionnée
Presenter:
Caroline Codeluppi & Fernanda Herrera, Centre Hospitalier Universitaire Vaudois, Lausanne
RTT Session 2
Chair:
Helen Mudry, Center Hospitalier Universitaire Vaudois, Lausanne
Importance of RTTs training (45')
Mary Coffey, Trinity Centre for Health Sciences, Dublin (IRL)
Unforeseen downtime on linear accelerators; How to deal with treatment interruptions. (45')
A review of radiobiological principels.
Adrien Cosinschi, Hôpital Riviera-Chablais
Multidisciplinary Symposium on Imaging for Radiotherapy
Chairs & introduction:
Shelley Bulling, Centre d'oncologie des Eaux-Vives, Geneva & Kathrin Zaugg, Stadtspital Triemli, Zurich
What can we expect from radiomics? (20')
Ralph leijenaar, University Maastricht (NLD)
PET-PSMA for diagnosis, follow-up & treatment of prostate carcinoma (20')
Osman Ratib, Hospital Riviera Chablais
MR Linac: what is the added value according to the physicist? (20')
Jan Lagendijk, UMC Utrecht (NLD)
The fourth major salivary gland: first description and clinical relevance for Radiotherapy (20')
Wouter Vogel & Matthijs Hugo Valstar, Netherlands Cancer Institute, Amsterdam (NLD)
Nurse: Requirements for ORL patients & the use of the functional scoring system MDASI
Cossette Schuler, Centre hospitalier universitaire vaudois, Lausanne & Frank Hof, Hôpitaux universitaires de Genève, Genève
Presenters:
Master students
Nurse: Team steep: the radiotherapy briefing
Sandrine Martelli, Hôpital Riviera-Chablais (HRC), Vaud-Valais
RTT: Proffered papers
Chair:
Joâo-Luis Soares-Rodrigues, Centre hospitalier universitaire vaudois, Lausanne
Co-Chair
Christian Dott, Universitätsspital Basel, Basel
- CyberHeart: Lausanne experience (CHUV)
- Hippocampus sparing whole brain radiotherapy planning with a biologic model (USZ).
- Quality manager. A new job in Radiotherapy (Hòpital du Valais Sion)
- Implementation of respiratory coaching in the management of left breast cancer using the deep inspiration breath hold technique (HFR Fribourg)
Poster discussion (II): a multidisciplinary session (Clinical / Physics / Biology) Questions / Answers with the investigators (10 abstracts)
Presenters & Chairs:
Raphael Moeckli, Centre Hospitalier Universitaire Vaudois, Lausanne & Oscar Matzinger, Clinique de Genolier
Nurse: Round table
Recommendations of care by radiations in the lesser pelvis (=pelvis minor)
Chair:
Susanne Sester, Inselspital Bern, Bern
Florence Kaufmann, Center Hospitalier Universitaire Vaudois, Lausanne
Coffee break
Symposium with industry what is “The Best Of” in 2019 & what will be available in 2020
Chairs and introduction:
Mahmut Ozsahin, Centre Hospitalier Universitaire Vaudois, Lausanne & Stephanie Tanadini-Lang, University Hospital, Zurich
Invited speakers from:
16:50 Peyre Ludovic, Accuray
17:00 Alexander Malesevic, Brainlab
17:10 Caroline Fraisse, Elekta
17:20 Piere-Justin Henri, RaySearch
17:30 Ekta Jhala, Varian
Conclusions:
Mahmut Ozsahin, Centre Hospitalier Universitaire Vaudois, Lausanne & Stephanie Tanadini-Lang, University Hospital, Zurich
SASRO General Assembly
Social Event
Saturday
Registration
Multidisciplinary Symposium: innovation in radiation oncology
Chairs:
Daniel Aebersold, Inselsptal Bern & Martin Pruschy, University Hospital, Zurich
What are the optimal particles for radiotherapy? (40')
The positive ones? Tony Lomax, Paul Scherrer Institut, Villigen
The negative ones? Mahmut Ozsahin, Centre Hospitalier Universitaire Vaudois, Lausanne
Up-date on Flash Therapy (20')
Jean Bourhis, Centre Hospitalier Universitaire Vaudois, Lausanne & Pierre Montay-Gruel, Université de Lausanne
Multidisciplinary Symposium on Multiple (>= 10) Brain Metastases
Chairs:
Evelyne Hermann, Inselspital Bern & Gianfranco Pesce, Ospedale Regionale di Bellinzona e Valli, Bellinzona
Whole brain RT or Stereo-RT? (20')
Luis Schiappacasse, Centre Hospitalier Universitaire Vaudois, Lausanne & Véronique Vallet, Centre Hospitalier Universitaire Vaudois, Lausanne
Update on molecular chemotherapy / molecular targeted therapy (15')
Roger von Moos, SAKK President, Chur
Immunotherapy (15')
Alfredo Addeo, HUG, Geneva